Nutrien Ltd. NTR NYSE

Nutrien Ltd. (NTR) generated $4.08B in operating cash flow for fiscal year 2025. After capital expenditures of $2.04B, free cash flow was $2.04B.

Free cash flow margin was 7.4% of revenue. Cash conversion ratio was 1.77x, indicating earnings are backed by cash.

The company returned $1.08B in dividends and $560.65M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (55/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (45/100) — Cash conversion ratio was 1.77x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 63/100 with 2/7 criteria passed.